
Manish Arun Rachchh
About Manish Arun Rachchh
Data last updated:
Manish Arun Rachchh has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Adeocure Lifesciences Private Limited and Accuprec Research Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Accuprec Research Labs Private Limited at ₹17.85 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2020 | 2012 | ₹17.85 Cr (FY 2023) | Active | |
| Director | 07 Oct 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manish Arun Rachchh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manish Arun Rachchh
Manish Arun Rachchh has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Adeocure Lifesciences Private Limited and Accuprec Research Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Accuprec Research Labs Private Limited at ₹17.85 Cr (FY 2023).
Manish Arun Rachchh is associated with 2 companies as Director, including Accuprec Research Labs Private Limited (₹17.85 Cr), Adeocure Lifesciences Private Limited.
Manish Arun Rachchh has expertise in General Business.
Manish Arun Rachchh has 6 years in corporate governance.
By reported revenue, the largest current company of Manish Arun Rachchh is Accuprec Research Labs Private Limited, with revenue of ₹17.85 Cr (FY 2023).
Manish Arun Rachchh currently holds positions at 2 companies: Accuprec Research Labs Private Limited (₹17.85 Cr), Adeocure Lifesciences Private Limited.